Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities

FASEB Journal

Volumn 26, Issue 9, 2012, Pages 3875-3883

  Yegutkin, Gennady G ^a,b   Wieringa, Bé ^b   Robson, Simon C ^c   Jalkanen, Sirpa ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Human and murine serum; Intravascular nucleotide homeostasis; Purinergic signaling

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADENYLATE KINASE 1; CD39 ANTIGEN; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANIMALS; ANTIGENS, CD; APYRASE; HUMANS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL;

MURINAE; MUS;

EID: 84865747829     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-205658     Document Type: Article

References (55)

1. Ralevic, V., and Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492
2. Marcus, A. J., Broekman, M. J., Drosopoulos, J. H., Islam, N., Pinsky, D. J., Sesti, C., and Levi, R. (2003) Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J. Pharmacol. Exp. Ther. 305, 9-16
3. Erlinge, D., and Burnstock, G. (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 4, 1-20
4. Mercier, N., Kiviniemi, T. O., Saraste, A., Miiluniemi, M., Silvola, J., Jalkanen, S., and Yegutkin, G. G. (2012) Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice. Am. J. Pathol. 180, 419-428
5. Yegutkin, G. G. (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783, 673-694
6. Gachet, C. (2006) Regulation of platelet functions by P2 receptors. Ann. Rev. Pharm. Toxicol. 46, 277-300
7. Robson, S. C., Wu, Y., Sun, X., Knosalla, C., Dwyer, K., and Enjyoji, K. (2005) Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemost. 31, 217-233
8. Kaczmarek, E., Koziak, K., Sevigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H., and Robson, S. C. (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-33122
9. Robson, S. C., Sevigny, J., and Zimmermann, H. (2006) The E-NTPDase family of ectonucleotidases: Structure function relationship and pathophysiological significance. Purinergic Signal. 2, 409-430
10. Knowles, A. F. (2011) The GDA1-CD39 superfamily: NTPDases with diverse functions. Purinergic Signal. 7, 21-45
11. Eltzschig, H. K., Kohler, D., Eckle, T., Kong, T., Robson, S. C., and Colgan, S. P. (2009) Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113, 224-232
12. Chalmin, F., Mignot, G., Bruchard, M., Chevriaux, A., Vegran, F., Hichami, A., Ladoire, S., Derangere, V., Vincent, J., Masson, D., Robson, S. C., Eberl, G., Pallandre, J. R., Borg, C., Ryffel, B., Apetoh, L., Rebe, C., and Ghiringhelli, F. (2012) Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36, 362-373
13. Enjyoji, K., Sevigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S., 2nd, Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., Beeler, D. L., Csizmadia, E., Wagner, D. D., Robson, S. C., and Rosenberg, R. D. (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5, 1010-1017
14. Pinsky, D. J., Broekman, M. J., Peschon, J. J., Stocking, K. L., Fujita, T., Ramasamy, R., Connolly, E. S., Jr., Huang, J., Kiss, S., Zhang, Y., Choudhri, T. F., McTaggart, R. A., Liao, H., Drosopoulos, J. H., Price, V. L., Marcus, A. J., and Maliszewski, C. R. (2002) Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J. Clin. Invest. 109, 1031-1040
15. Hart, M. L., Gorzolla, I. C., Schittenhelm, J., Robson, S. C., and Eltzschig, H. K. (2010) SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J. Immunol. 184, 4017-4024
16. Dwyer, K. M., Robson, S. C., Nandurkar, H. H., Campbell, D. J., Gock, H., Murray-Segal, L. J., Fisicaro, N., Mysore, T. B., Kaczmarek, E., Cowan, P. J., and d'Apice, A. J. (2004) Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J. Clin. Invest. 113, 1440-1446
17. Wheeler, D. G., Joseph, M. E., Mahamud, S. D., Aurand, W. L., Mohler, P. J., Pompili, V. J., Dwyer, K. M., Nottle, M. B., Harrison, S. J., d'Apice, A. J., Robson, S. C., Cowan, P. J., and Gumina, R. J. (2012) Transgenic swine: expression of human CD39 protects against myocardial injury Wheeler, CD39 reduces myocardial injury in swine. J. Mol. Cell. Cardiol. 52, 958-961
18. Gayle, R. B., 3rd, Maliszewski, C. R., Gimpel, S. D., Schoenborn, M. A., Caspary, R. G., Richards, C., Brasel, K., Price, V., Drosopoulos, J. H., Islam, N., Alyonycheva, T. N., Broekman, M. J., and Marcus, A. J. (1998) Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J. Clin. Invest. 101, 1851-1859
19. Schulte am Esch, J., 2nd, Sevigny, J., Kaczmarek, E., Siegel, J. B., Imai, M., Koziak, K., Beaudoin, A. R., and Robson, S. C. (1999) Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry 38, 2248-2258
20. Coade, S. B., and Pearson, J. D. (1989) Metabolism of adenine nucleotides in human blood. Circ. Res. 65, 531-537
21. Yegutkin, G. G., Samburski, S. S., and Jalkanen, S. (2003) Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J. 17, 1328-1330
22. Cauwenberghs, S., Feijge, M. A., Hageman, G., Hoylaerts, M., Akkerman, J. W., Curvers, J., and Heemskerk, J. W. (2006) Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation. Transfusion 46, 1018-1028
23. Yegutkin, G. G., Samburski, S. S., Mortensen, S. P., Jalkanen, S., and Gonzalez-Alonso, J. (2007) Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. J. Physiol. 579, 553-564
24. Banz, Y., Beldi, G., Wu, Y., Atkinson, B., Usheva, A., and Robson, S. C. (2008) CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation. Br. J. Haematol. 142, 627-637
25. Yan, H., and Tsai, M.-D. (1999) Nucleoside monophosphate kinases: structure, mechanism, and substrate specificity. Adv. Enzymol. Relat. Areas Mol. Biol. 73, 103-134
26. Noma, T. (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J. Med. Invest. 52, 127-136
27. Janssen, E., Dzeja, P. P., Oerlemans, F., Simonetti, A. W., Heerschap, A., de Haan, A., Rush, P. S., Terjung, R. R., Wieringa, B., and Terzic, A. (2000) Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J. 19, 6371-6381
28. Janssen, E., Kuiper, J., Hodgson, D., Zingman, L. V., Alekseev, A. E., Terzic, A., and Wieringa, B. (2004) Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Mol. Cell. Biochem. 256-257, 59-72
29. Dzeja, P. P., Chung, S., and Terzic, A. (2007) Integration of adenylate kinase, glycolytic and glycogenolytic circuits in cellular energetics. In Molecular System Bioenergetics, Vol. 8 (Saks, V., ed.) pp. 265-302, Wiley-VCH, Weinheim
30. Collavin, L., Lazarevic, D., Utrera, R., Marzinotto, S., Monte, M., and Schneider, C. (1999) wt p53 dependent expression of a membrane-associated isoform of adenylate kinase. Oncogene 18, 5879-5888
31. Choo, H. J., Kim, B. W., Kwon, O. B., Lee, C. S., Choi, J. S., and Ko, Y. G. (2008) Secretion of adenylate kinase 1 is required for extracellular ATP synthesis in C2C12 myotubes. Exp. Mol. Med. 40, 220-228
32. Yegutkin, G. G., Henttinen, T., and Jalkanen, S. (2001) Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J. 15, 251-260
33. Donaldson, S. H., Picher, M., and Boucher, R. C. (2002) Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am. J. Respir. Cell Mol. Biol. 26, 209-215
34. Muller, C. E., Iqbal, J., Baqi, Y., Zimmermann, H., Rollich, A., and Stephan, H. (2006) Polyoxometalates - a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg. Med. Chem. Lett. 16, 5943-5947
35. Crack, B. E., Pollard, C. E., Beukers, M. W., Roberts, S. M., Hunt, S. F., Ingall, A. H., McKechnie, K. C., AP, I. J., and Leff, P. (1995) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol. 114, 475-481
36. Levesque, S. A., Lavoie, E. G., Lecka, J., Bigonnesse, F., and Sevigny, J. (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br. J. Pharmacol. 152, 141-150
37. Chen, B. C., Lee, C. M., and Lin, W. W. (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br. J. Pharmacol. 119, 1628-1634
38. Yegutkin, G. G., and Burnstock, G. (2000) Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes. Biochim. Biophys. Acta 1466, 234-244
39. Jorgensen, S. (1956) Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta Pharmacol. Toxicol. 12, 294-302
40. Goding, J. W., Grobben, B., and Slegers, H. (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family. Biochim. Biophys. Acta 1638, 1-19
41. Park, W., Masuda, I., Cardenal-Escarcena, A., Palmer, D. W., and McCarty, D. J. (1996) Generation of inorganic pyrophosphate from extracellular adenosine triphosphate by human serum and plasma. J. Rheumatol. 23, 1233-1236
42. Ireland, D. M., and Mills, D. C. (1966) Detection and determination of adenosine diphosphate and related substances in plasma. Biochem. J. 99, 283-296
43. Sunderman, F. W., Jr. (1990) The clinical biochemistry of 5′-nucleotidase. Ann. Clin. Lab. Sci. 20, 123-139
44. Haslam, R. J., and Mills, D. C. (1967) The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem. J. 103, 773-784
45. Todorov, L. D., Mihaylova-Todorova, S., Westfall, T. D., Sneddon, P., Kennedy, C., Bjur, R. A., and Westfall, D. P. (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387, 76-79
46. Sorensen, C. E., Amstrup, J., Rasmussen, H. N., Ankorina-Stark, I., and Novak, I. (2003) Rat pancreas secretes particulate ecto-nucleotidase CD39. J. Physiol. 551, 881-892
47. Yegutkin, G. G., Samburski, S. S., Jalkanen, S., and Novak, I. (2006) ATP-consuming and ATP-generating enzymes secreted by pancreas. J. Biol. Chem. 281, 29441-29447
48. Yegutkin, G., Bodin, P., and Burnstock, G. (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br. J. Pharmacol. 129, 921-926
49. Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., and Colgan, S. P. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783-796
50. Eltzschig, H. K., and Carmeliet, P. (2011) Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665
51. Robson, S. C., Kaczmarek, E., Siegel, J. B., Candinas, D., Koziak, K., Millan, M., Hancock, W. W., and Bach, F. H. (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 185, 153-163
52. Yegutkin, G. G., Helenius, M., Kaczmarek, E., Burns, N., Jalkanen, S., Stenmark, K., and Gerasimovskaya, E. V. (2011) Chronic hypoxia impairs extracellular nucleotide metabolism and barrier function in pulmonary artery vasa vasorum endothelial cells. Angiogenesis 14, 503-513
53. Straub, A., Krajewski, S., Hohmann, J. D., Westein, E., Jia, F., Bassler, N., Selan, C., Kurz, J., Wendel, H. P., Dezfouli, S., Yuan, Y., Nandurkar, H., Jackson, S., Hickey, M. J., and Peter, K. (2011) Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler. Thromb. Vasc. Biol. 31, 1607-1616
54. Buergler, J. M., Maliszewski, C. R., Broekman, M. J., Kaluza, G. L., Schulz, D. G., Marcus, A. J., Raizner, A. E., Kleiman, N. S., and Ali, N. M. (2005) Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model. J. Thromb. Thrombolysis. 19, 115-122
55. Berry, C. E., and Hare, J. M. (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555, 589-606